Prostatic Neoplasms: all 6,484 studies
Page 41 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With InsomniaCompletedNCT03444532Not applicable
- Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate CancerCompletedNCT03443609Not applicable
- Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic BiopsyCompletedNCT03442075
- Feasibility of the LUM Imaging System for Detection of Prostate CancerTerminatedNCT03441464Phase 1/2
- Androgen Deprivation Therapy Muscle Protein Metabolism and Blood GlucoseTerminatedNCT03440879Not applicable
- Non-contrast MR Imaging for Whole Body Cancer Detection and CharacterizationStatus unknownNCT03440554Not applicable
- Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor RecurrenceActive, not recruitingNCT03438552Not applicable
- Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic AdenocarcinomaActive, not recruitingNCT03436654Phase 2
- Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)CompletedNCT03434158Phase 2
- Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPCActive, not recruitingNCT03432949Phase 4
- Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate CancerStatus unknownNCT03432780Phase 2
- Early and Accurate Detection of Prostate Cancer in General PracticeStatus unknownNCT03431753Not applicable
- Prostate Impendance Test ProjectStatus unknownNCT03428087
- LDR vs. HDR Brachytherapy for Prostate CancerActive, not recruitingNCT03426748Not applicable
- Intra-operative Neuromodulation of the Pelvic PlexusStatus unknownNCT03425240Not applicable
- A Survivorship Care Plan and Embedded Navigation ToolCompletedNCT03424837Not applicable
- HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate CancerCompletedNCT03424694Not applicable
- Race-related Alternative Splicing: Novel Targets in Prostate CancerCompletedNCT03424213
- Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer PatientsCompletedNCT03423927Not applicable
- Fatigue Interventions in Cancer (Exercise Intervention)CompletedNCT03421782Phase 2
- Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic EvolutionCompletedNCT03421015
- The "PC-LIGHT" StudyCompletedNCT03419585Not applicable
- Multi-academic Center Study of Xofigo PatientsCompletedNCT03419442
- The Accuracy of Modified TTMB in the Spatial Distribution of Prostate CancerStatus unknownNCT03418207Not applicable
- Exercising Together During Radiation TreatmentCompletedNCT03418025Not applicable
- Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)Status unknownNCT03414437
- Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective TrialStatus unknownNCT03413007
- Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node MetastasesCompletedNCT03412786Phase 1
- Social Media Listening in Improving Clinical Trial Recruitment in Patients With CancerWithdrawnNCT03408561Not applicable
- Feasibility of Prostatic Arterial Embolization in Low-risk Patients With Unilateral Prostate Cancer Under Active Surveillance: Monocentric Pilot StudyCompletedNCT03407963Not applicable
- Internet-Based Exercise and Diet Support in Prostate Cancer SurvivorsCompletedNCT03406013Not applicable
- 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate CancerStatus unknownNCT03403595Phase 1
- Pioneering Advances in Care and Education (PACE)CompletedNCT03397160Not applicable
- Impact of Exercise on Prognostic Biomarkers Related to Prostate CancerCompletedNCT03397030Not applicable
- Sexual Health and Rehabilitation eClinic (SHAReClinic)Status unknownNCT03396848Not applicable
- A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate CancerCompletedNCT03392428Phase 2
- PET/MRI for the Staging of Newly Diagnosed Prostate CancerActive, not recruitingNCT03392181Early Phase 1
- Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™CompletedNCT03390127Not applicable
- Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer ScreeningCompletedNCT03387527Not applicable
- Investigating Bone and Skeletal Muscle Interaction in Men With Prostate CancerCompletedNCT03386812
- Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With TrametinibNo longer availableNCT03386071
- Optimal Prostate StudyActive, not recruitingNCT03386045Not applicable
- Prostate Cancer Biomarker Enrichment and Treatment SelectionActive, not recruitingNCT03385655Phase 2
- Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local MicrobiomeCompletedNCT03383107
- Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)Active, not recruitingNCT03383016
- Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate CarcinomaCompletedNCT03382522
- CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.Active, not recruitingNCT03381326
- From PSA to Stockholm3: Study Part 1Active, not recruitingNCT03381105
- Prostate Boost Irradiation With Stereotactic Body RT (SBRT)Status unknownNCT03380806Phase 2
- Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion BiopsiesActive, not recruitingNCT03377881Not applicable
- Functional Medical Imaging Quantization in Prostate CancerCompletedNCT03376360
- The Impact of Low Pressure Pneumo in RARPCompletedNCT03370016Not applicable
- The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.CompletedNCT03368989
- 68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before SurgeryCompletedNCT03368547Not applicable
- Early DVC Ligation and Urinary Continence Recovery After RARPCompletedNCT03368378Not applicable
- Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBTCompletedNCT03365518Not applicable
- Therapeutics in Active Prostate Cancer SurveillanceCompletedNCT03365297Phase 2
- Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)TerminatedNCT03365076Not applicable
- Ga-68-PSMA-11 in High-risk Prostate CancerCompletedNCT03362359Phase 1/2
- Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.CompletedNCT03361969Phase 2
- Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate CancerTerminatedNCT03360721Phase 2
- Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate CancerCompletedNCT03358563Early Phase 1
- CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based ChemotherapyStatus unknownNCT03356912Phase 2
- Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the ProstateStatus unknownNCT03356444Phase 2
- Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical ProstatectomyStatus unknownNCT03351088Not applicable
- MRI Guided Transurethral HIFU for Various Prostate DiseasesCompletedNCT03350529Not applicable
- Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer STARTCompletedNCT03348722
- Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide PolymorphismsActive, not recruitingNCT03348670Phase 2/3
- A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate CancerCompletedNCT03348527Phase 2
- Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer PatientsStatus unknownNCT03344822Phase 2/3
- Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate CancerActive, not recruitingNCT03344211Phase 2
- Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)WithdrawnNCT03343977Phase 1/2
- PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.Status unknownNCT03340272
- Optimized 2D-RT for Prostate CancerCompletedNCT03339531Not applicable
- Micro-RNA Expression Profiles in Localised Prostate CancerWithdrawnNCT03338712
- Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer PatientsCompletedNCT03336983Phase 2
- Preference-Based Exercise RCT for Men With PC on ADTCompletedNCT03335631Not applicable
- Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate CancerActive, not recruitingNCT03334500Early Phase 1
- Randomized Trial of eOncoNoteCompletedNCT03333785Not applicable
- Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility StudyCompletedNCT03331458Not applicable
- Investigating and Characterizing the Immune Response to Prostate CancerCompletedNCT03331367Not applicable
- French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer.CompletedNCT03331068
- Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate CancerCompletedNCT03329742Not applicable
- A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in SwedenCompletedNCT03328364
- Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)CompletedNCT03328091Not applicable
- Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealthStatus unknownNCT03327103Not applicable
- Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate CancerCompletedNCT03326440Not applicable
- Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review StudyWithdrawnNCT03325127
- Combined LDR Boost and HDR Whole GlandTerminatedNCT03323879Phase 1/2
- Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate CancerCompletedNCT03322020Phase 1/2
- Capture of Prostatic Trans-rectal Ultrasound Scans for ResearchSuspendedNCT03321864Not applicable
- Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation TherapyCompletedNCT03321149Not applicable
- The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal TherapyCompletedNCT03315585Not applicable
- Treatment Satisfaction With Ra-223 in JapanCompletedNCT03315260
- The Effect of ADT on PSMA-PET.Status unknownNCT03313726Not applicable
- Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior RadiotherapyActive, not recruitingNCT03312972Not applicable
- AZD5363 in Patients With Advanced Solid Tumors Harboring AKT MutationsCompletedNCT03310541Phase 1
- Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate CancerWithdrawnNCT03308734Not applicable
- uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor AggressivenessStatus unknownNCT03307460Phase 2
- The Combination Therapy With Ra-223 and EnzalutamideStatus unknownNCT03305224Phase 2